2. Arner S, Arner B: Differential effects of epidural morphine in the treatment of cancer-related pain. Acta Anaesthesiol Scand 29:32-36, 1985

*3. Averbuch SD: New bisphosphonates in the treatment of bone metastases. Cancer 72 (11 Suppl):3443-52, 1993 (Review)

4. Boersma FP, Noorduin H, Bussche GV: Epidural sufentanil for cancer pain control in outpatients. Reg Anesth 14:293-297, 1989

5. Bonica JJ: Treatment of cancer pain: Current status and future needs. In: Fields HL, Dubner R, Cervero F, eds. Advances In Pain Research and Therapy. New York: Raven Press, 9:589-616, 1985

6. Brown D: A retrospective analysis of neurolytic celiac plexus block for nonpancreatic intra-abdominal cancer pain. Reg Anesth 14:63-65, 1989

7. Cameron LB: Neuropsychotropic drugs as adjuncts in the treatment of cancer. Oncology (Huntingt) 6:65-72, discussion 72; 77-80, 1992

*8. Cherny NI, Portenoy RK: The management of cancer pain. CA Cancer J Clin 44:263-303, 1994 (Review)

9. Coombs DW, Fratkin JD, Meier FA, Nierenberg DW, Saunders RL: Neuropathologic lesions and CSF morphine concentrations during chronic continuous intraspinal morphine infusion. A clinical and post-mortem study: Pain 22:337-351, 1985

10. Coombs DW, Saunders RL, Lachance D, Savage S, Ragnarsson TS, Jensen LE: Intrathecal morphine tolerance: use of intrathecal clonidine, DADLE, and intraventricular morphine. Anesthesiology 62:358-363, 1985

11. Cousins MJ, Reeves TS, Glysin CJ, Walsh JA, Cherry DA: Neurolytic lumbar sympathetic blockade duration of denervation and relief of rest pain. Anaesth Intens Care 7:121-135, 1979

12. Downing JE, Busch EH, Stedman PM: Epidural morphine delivered by a percutaneous epidural catheter for outpatient treatment of cancer pain. Anesth Analg 67:1159-1161, 1988.

12. Evans RJ, Mackay IM: Subarachnoid phenol nerve blocks for relief of pain in advanced malignancy. Can J Surg 15:50-53, 1972

*13. Fainsinger R, Schoeller T, Bruera E: Methadone in the management of cancer pain. Pain 52:137-47:1993 (Review)

14. Ferrer-Brechner T: The management of pain associated with malignancy. Sem Anesth 4:313-322, 1985

15. Foley KM: The treatment of cancer pain. N Engl J Med 313:84-95, 1985

16. Follett KA, Hitchon PW, Piper J, Kumar V, Clamon G, Jones MP: Response of intractable pain to continuous intrathecal morphine: a retrospective study. Pain 49:21-25, 1992

17. Gourlay GK, Plummer JL, Cherry DA, Onley MM, Parish KA, Wood MM, Cousins MJ: Comparison of intermittent bolus with continuous infusion of epidural morphine in the treatment of severe cancer pain. Pain 47:135-140, 1991

*18. Grant R, Papadopoulos SM, Greenberg HS. Metastatic epidural spinal cord compression. Neurol Clin 9:825-41, 1991 (Review)

*19. Hassenbusch SJ: Surgical management of cancer pain. Neurosurg Clin N Am 6127-34, 1995(Review)

*20. Lamer TJ: Treatment of cancer-related pain: when orally administered medications fail. Mayo Clin Proc. 69:473-80, 1994 (Reveiw)

21. Lebovits AH, Lefkowitz M: Pain management of pancreatic carcinoma: a review. Pain 36:1-11, 1989

22. Malone BT, Beye R, Walker J: Management of pain in the terminally ill by administration of epidural narcotics. Cancer 55:438-440, 1985

23. Miser, AW, Narang PK, Dothage JA, Young RC, Sindelar W, Miser JS: Transdermal fentanyl for pain control in patients with cancer. Pain 37:15-21, 1989

24. Onofrio BM, Yaksh TL, Arnold PG: Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc 56:516-520, 1981

*25. Payne R: Transdermal fentanyl: suggested recommendations for clinical use. J Pain Symptom Manage 7 (3 Suppl):S40-4, 1992 (Review)

26. Rodan BA, Cohen FL, Bean WJ, Martyak SN: Fibrous mass complicating epidural morphine infusion. Neurosurg 16:68-70, 1985

27. Samuelsson H, Nordberg G, Hedner T, Lindqvist J: CSF and plasma morphine concentrations in cancer patients during chronic epidural morphine therapy and its relation to pain relief. Pain 30:303-310, 1987.

28. Samuelsson H, Hedner T: Pain characterization in cancer patients and the analgetic response to epidural morphine. Pain 46:3-8, 1991

29. Sj”berg M, Appelgren L, Einarsson S, Hultman E, Linder LE, Nitescu P, Curelaru I: Long-term intrathecal morphine and bupivacaine in "refractory" cancer pain. I. Results from the first series of 52 patients. Acta Anaesthesiol Scand 35:30-43, 1991

30. Sj”berg M, Karlsson P-A, Nordborg C, Wallgren A, Nitescu P, Appelgren L, Linder L-E, Curelaru I: Neuropathologic findings after long-term intrathecal infusion of morphine and bupivacaine for pain treatment in cancer patients. Anesthesiology 76:173-186, 1992

*31. Sundaresan N, Suite ND: Optimal use of the ommaya reservoir in clinical oncology. Oncology (Huntingt) 3:15-22;discussion 23, 1989 (Review)

32. Thompson GE, Moore DC, Bridenbaugh LD, Artin RY: Abdominal pain and alcohol-celiac plexus nerve block. Anesth Analg 56:1-5, 1977

*33. Twycross RG: Management of pain in skeletal metastases. Clin Orthop 312:187-96, 1995 (Review)

34. Ventafridda V, Spoldi E, Caraceni A, et al: The importance of continuous subcutaneous morphine administration for cancer pain. Pain Clin 1:47-55, 1986

35. Wall PD: Cancer pain: Neurogenic mechanisms. In: Fields HL, Dubner R, Cervero F, eds. Advances in Pain Research and Therapy. New York: Raven Press, 9:575-587, 1985

36. Yaksh TL, Reddy SVR: Studies in the primate on the analgesic effects associated with intrathecal actions of opiate, alpha adrenergic agonists and baclofen. Anesthesiology 54:451-467, 1981